RKDA
Arcadia Biosciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 1
Significant Net Income Growth
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About RKDA
Arcadia Biosciences, Inc.
A provider of agricultural products and technology solutions focused on improving crop yields and sustainability
5950 Sherry Lane, Suite 215, Dallas, TX 75225
--
Arcadia Biosciences, Inc. was founded in Arizona in 2002 and reorganized in Delaware in March 2015. The company is a manufacturer and marketer of innovative plant-based food and beverage products. The company has historically been a leader in the scientific approach to developing high-value crop improvements (primarily wheat) with the goal of improving agricultural economics by improving the performance of crops in the field and their value as food feedstocks. The company has developed these patented innovations using non-GMO advanced breeding technologies, which the company is currently commercializing through the sale of seeds and grains, food ingredients and products, trait licensing and licensing agreements.
Earnings Call
Q1/2025
Estimate EPS--
Actual EPS1.9
Estimate Revenue1.30M
Actual Revenue1.20M
Arcadia Biosciences Q1 2025: Unpacking Contradictions in Distribution Growth, Margins, and Future Monetization
May 19,2025 09:46
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
RKDA has released its 2024 Q4 earnings. EPS was reported at -2.98, versus the expected -0.68, missing expectations. The chart below visualizes how RKDA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
RKDA has released its 2025 Q1 earnings report, with revenue of 1.20M, reflecting a YoY change of 21.58%, and net profit of 2.60M, showing a YoY change of 207.26%. The Sankey diagram below clearly presents RKDA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
